PEDIATRIC SOLID TUMOR
Clinical trials for PEDIATRIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for PEDIATRIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with relapsed cancers: experimental drug CLR 131 enters early trial
Disease control OngoingThis early-phase study tests an experimental drug called CLR 131 in children, adolescents, and young adults (ages up to 30) with certain cancers that have come back or not responded to standard treatments. The cancers include solid tumors (like neuroblastoma and sarcomas), lympho…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
Immune cells engineered to fight childhood cancers enter first human tests
Disease control OngoingThis early-phase study tests a new treatment for children and young adults (up to age 26) with solid tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack a protein c…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 26, 2026 05:41 UTC
-
Engineered immune cells take aim at childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (ages 1–30) whose solid tumors have come back or not responded to standard treatment. Researchers take a patient's own immune T cells, modify them to recognize and attack cancer cells that carr…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Gene testing guides cancer therapy for kids: a step toward precision medicine
Knowledge-focused OngoingThis study looks at whether testing the genes in a child's solid tumor can help doctors choose a targeted therapy that might work better. It involves 825 children and young adults up to age 30 whose cancer has come back or not responded to standard treatment. The goal is to see i…
Matched conditions: PEDIATRIC SOLID TUMOR
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:44 UTC